Where wearable studies actually fail
A validated device is not a validated study.
ActivInsights has built real scientific credibility around GENEActiv — published, peer-reviewed algorithms on a research-grade accelerometer. That depth matters for activity and sleep endpoints. But endpoint integrity in a live trial also depends on whether participants keep wearing the device, whether the data arrives complete, and whether your protocol needs more than one device class. Those are signal-quality and execution problems, and they are where Delve specializes.
Bottom line: If your study is a single-device actigraphy protocol and you want a specific validated device, ActivInsights is a strong, credible choice. If your study spans multiple devices, needs wear-time recovery, signal QC, and a path to a usable endpoint across the whole population, Delve is the better-fitting platform.
Where ActivInsights and Delve genuinely overlap
At the capability level, both can support a modern wearable-enabled trial. Both typically offer:
- Validated, regulatory-grade digital measures (activity, sleep, actigraphy)
- A focus on data quality and defensible endpoints
- Research-grade device data rather than consumer-only metrics
- Support for objective, sensor-derived outcomes in submissions
The differences show up once you ask what happens when a participant stops wearing the device, when a sensor produces unusable data, or when an endpoint depends on validated algorithms across more than one device.
Side-by-side comparison
ActivInsights vs Delve Health: capability comparison
The table reflects publicly documented positioning and standard delivery models for each platform. Specific configurations vary by contract.
| Capability | ActivInsights | Delve Health |
|---|---|---|
| Signal quality & endpoint integrity | ||
| Validated digital-endpoint algorithms | Yes — published, peer-reviewed, for GENEActiv | 70+ algorithms across ECG, glucose, activity, sleep, QC — many device classes |
| Device breadth | Primarily the GENEActiv device family | 25+ devices on one harmonized data layer |
| Signal quality control / completeness | Device-level data quality | Active QC layer — completeness, drift, sync-failure detection |
| Wear-time recovery (human) | Not a concierge model | Built in — proactive outreach before wear-time decays |
| Human concierge patient support | No | 120+ languages, built into the platform |
| eCOA / ePRO included | Sensor-data focus | Fully configurable eCOA alongside wearables |
| Device logistics & provisioning | Supply of own hardware | End-to-end across devices, BYOD or provisioned |
| Per-study completion accountability | Customer-driven | 92–98% documented per study |
| Compliance posture (HIPAA, GDPR, 21 CFR Part 11, GCP, ISO 27001) | Yes | Yes |
Why wearable-heavy studies pick Delve
Four reasons sponsors choose Delve when wearable endpoint integrity, wear-time, or retention is the deliverable — not the customer's problem to solve.
Completion is the deliverable
Delve publishes documented 92–98% per-study eCOA/ePRO completion ranges and up to 63% retention uplift in long-duration cohorts — platform-owned, not the customer's problem to solve.
Validated algorithms across many devices
70+ validated digital-endpoint algorithms across 25+ devices on one harmonized data layer that normalizes units, sampling rates, time bases, QC flags, and algorithm versions.
Signal quality, owned end-to-end
Signal quality control validates completeness, flags drift, and catches sync failures before data is lost — not discovered at database lock.
Humans recover wear-time
Concierge-as-a-Service in 120+ languages recovers participants before wear-time decays — proactive outreach, device troubleshooting, escalation.
Which platform fits your study
Choose the platform that fits your operating model
Choose ActivInsights if…
- Your protocol is a single-device actigraphy / activity / sleep study
- You specifically want the GENEActiv device and its published validation library
- You have in-house capacity to manage wear-time, data completeness, and patient support
- You are sourcing a validated sensor, not a full trial-execution platform
Choose Delve Health if…
- Your study spans more than one device class and you need validated algorithms across all of them
- You need signal quality control and sync-failure detection before data is lost
- You want human concierge to recover wear-time in 120+ languages
- You want eCOA, logistics, and analytics in one operating model
- You want documented per-study completion (92–98%) as a deliverable
Frequently asked questions
Questions sponsors ask when comparing ActivInsights and Delve Health
Is Delve Health an ActivInsights / GENEActiv alternative?
Yes, with a different scope. ActivInsights provides a validated research-grade accelerometer (GENEActiv) with published algorithms. Delve Health is a wearable execution platform that runs validated algorithms across many device classes and adds signal quality control, wear-time recovery, eCOA, and concierge support. Single-device studies may prefer ActivInsights; multi-device, execution-critical studies typically prefer Delve.
What is the difference between validated algorithms for one device and across many?
ActivInsights validates algorithms deeply for its own device. Delve runs 70+ validated digital-endpoint algorithms across 25+ devices on a harmonized data layer that normalizes units, sampling rates, time bases, and QC flags. If your endpoint depends on more than one device class, multi-device validation and harmonization matter as much as single-device depth.
Does ActivInsights include human patient support or wear-time recovery?
ActivInsights focuses on validated device data, not a concierge support model. Delve includes Concierge-as-a-Service in 120+ languages that proactively recovers participants before wear-time decays, which is one of the largest drivers of completion in wearable studies.
Which is better for activity and sleep endpoints?
Both can support activity and sleep endpoints. ActivInsights offers strong single-device validation. Delve offers validated activity and sleep algorithms across multiple devices plus the signal QC and wear-time execution that protect the endpoint across a full study population.
Can Delve work alongside a device like GENEActiv?
Delve integrates many device classes. The deciding question for sponsors is usually whether they want a validated device on its own, or a platform that turns any supported device into a usable endpoint with QC, wear-time recovery, and eCOA around it.
Evaluating Delve against ActivInsights?
Ask each vendor one question: what happens to your endpoint when a participant stops wearing the device? The answer tells you more than any device list.
Book a Platform Walkthrough